Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity

摘要

Disclosed are a class of isoquinoline compounds acting as RHO protein kinase inhibitors, and the use thereof in the preparation of a drug for treating diseases associated with RHO protein kinase. Particularly disclosed are compounds as shown in formula (I) and pharmaceutically acceptable salts thereof.;